IPO Review: Corona Remedies
Moneylife Digital Team 09 December 2025
Corona Remedies (Corona), an Ahmedabad-based pharmaceutical formulations company, operates across women's healthcare, cardio-diabetic-care, pain management and urology segments. The firm manages...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
ACME Solar: Growth Visibility Improves, but Valuation Risk Looms
Moneylife Digital Team 08 December 2025
Acme Solar Holdings Limited (ACME) has evolved from an early utility-scale solar developer into an integrated platform spanning solar, wind, hybrid and firm and dispatchable renewable energy (FDRE) projects with in-house...
Mankind Pharma: Revenue Growth but Margins under Pressure
Moneylife Digital Team 08 December 2025
Mankind Pharma Limited (Mankind) delivered robust top-line expansion in Q2FY25-26, posting revenues of ₹3,697 crore and marking a 20.8% year-on-year (y-o-y) increase. The growth was driven by strength in the underlying business...
Belrise Industries: Next Phase of Growth with EV-led Pipeline and New Facilities
Moneylife Digital Team 08 December 2025
Belrise Industries, one of India's leading auto-component manufacturers, delivered a strong Q2FY25-26, reporting a 14% year-on-year (y-o-y) jump in revenue to ₹2,354 crore. The performance was helped by robust domestic automotive...
Market This Week
Moneylife Digital Team 05 December 2025
India's capital markets presented a study in divergence this week. Foreign portfolio investors (FPIs) demonstrated marked caution, contrasting with the sustained absorption of domestic mutual funds. FPIs withdrew a net US$933mn...
Free Helpline
Legal Credit
Feedback